Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Metotrexato")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2717

  • Page / 109
Export

Selection :

  • and

Toward a better understanding of methotrexateKREMER, Joel M.Arthritis and rheumatism. 2004, Vol 50, Num 5, pp 1370-1382, issn 0004-3591, 13 p.Article

Mesial Temporal Sclerosis Associated With Methotrexate-Induced LeukoencephalopathyHAMAMOTO, Kouhei; ORIUCHI, Noboru; KANAZAWA, Takashi et al.Pediatric neurology. 2009, Vol 40, Num 4, pp 306-309, issn 0887-8994, 4 p.Article

Synergistic interaction between methotrexate and a superoxide dismutase mimetic : Pharmacologic and potential clinical significanceCUZZOCREA, Salvatore; MAZZON, Emanuela; DI PAOLA, Rosanna et al.Arthritis and rheumatism. 2005, Vol 52, Num 12, pp 3755-3760, issn 0004-3591, 6 p.Article

Liver biopsies and methotrexate : A time for reconsideration?ZACHARIAE, H.Journal of the American Academy of Dermatology. 2000, Vol 42, Num 3, pp 531-534, issn 0190-9622Article

Optimal administration and dosage of methotrexateBRAUN, J.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 5, issn 0392-856X, S46-S51, SUP61Article

Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologistsGOSSEC, L; BIJLSMA, J. W. J; MIELANTS, H et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 2, pp 388-389, issn 0003-4967, 2 p.Article

Les stratégies d'utilisation du méthotrexateWENDLING, Daniel.Rhumatos. 2010, Vol 7, Num 60, pp 2-4, issn 1771-0081, 3 p., CAH2Article

Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION studySAURAT, J.-H; LANGLEY, R. G; REICH, K et al.British journal of dermatology (1951). 2011, Vol 165, Num 2, pp 399-406, issn 0007-0963, 8 p.Article

Lettre d'information pour le traitement du psoriasis par méthotrexate = Information letter on treatment of psoriasis with methotrexateAnnales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 861-862, issn 0151-9638, 2 p.Article

Éléments prédictifs de la réponse thérapeutique au méthotrexateCANTAGREL, Alain.Revue du rhumatisme (Ed. française). 2010, Vol 77, pp 4-9, issn 1169-8330, 6 p., HS1Article

Initiative 3 E: Evidence, Expertise, ExchangeWENDLING, Daniel.Rhumatos. 2010, Vol 7, Num 58, pp 5-6, issn 1771-0081, 2 p., CAH3Article

Use of methotrexate in patients with psoriasisKUHN, A; RULAND, V; PATSINAKIDIS, N et al.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 5, issn 0392-856X, S138-S144, SUP61Article

Methotrexate safety: from prescribing to labellingAL-NIAIMI, F; COX, N. H.British journal of dermatology (1951). 2009, Vol 160, Num 6, pp 1345-1346, issn 0007-0963, 2 p.Article

Methotrexate for psoriasis in the era of biological therapyWARREN, R. B; CHALMERS, R. J. G; GRIFFITHS, C. E. M et al.Clinical and experimental dermatology (Print). 2008, Vol 33, Num 5, pp 551-554, issn 0307-6938, 4 p.Article

Foie et méthotrexate = The liver and methotrexateLAHANE, D; TERREBONNE, E; VERGNIOL, J et al.Gastroentérologie clinique et biologique. 2008, Vol 32, Num 2, pp 134-142, issn 0399-8320, 9 p.Article

Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic diseaseVAN TROMMEL, Nienke E; MASSUGER, Leon F; SCHIJF, Charles P et al.Journal of clinical oncology. 2006, Vol 24, Num 1, pp 52-58, issn 0732-183X, 7 p.Article

Anomalies associated with failed methotrexate and misoprostol terminationYEDLINSKY, Nicole T; MORGAN, Frank C; WHITECAR, Paul W et al.Obstetrics and gynecology (New York. 1953). 2005, Vol 105, Num 5, pp 1203-1205, issn 0029-7844, 3 p., 2Article

Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic end-pointsHONGPING DENG; MEIBIAN ZHANG; JILIANG HE et al.Mutagenesis. 2005, Vol 20, Num 5, pp 351-357, issn 0267-8357, 7 p.Article

A rare drug reaction to methotrexate after treatment for ectopic pregnancySTRAKA, Michele; ZERINGUE, Ernest; GOLDMAN, Mindy et al.Obstetrics and gynecology (New York. 1953). 2004, Vol 103, Num 5, pp 1047-1048, issn 0029-7844, 2 p., 2Article

Bilateral subdural hygromas following intrathecal methotrexateLOKIREDDY, Padmaja; DYER, Martin J. S.British journal of haematology. 2011, Vol 155, Num 5, issn 0007-1048, p. 536Article

Discontinuation of Methotrexate in PsoriasisDUE, Eva; BLOMBERG, Maria; SKOV, Lone et al.Acta dermato-venereologica. 2012, Vol 92, Num 4, pp 353-354, issn 0001-5555, 2 p.Article

Use of methotrexate in young patients with respect to the reproductive systemGROMNICA-IHLE, E; KRÜGER, K.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 5, issn 0392-856X, S80-S84, SUP61Article

Folate with methotrexate : big benefit, questionable costBROWNELL, I; STROBER, B. E.British journal of dermatology (1951). 2007, Vol 157, Num 1, issn 0007-0963, 213Article

Exposition paternelle au méthotrexateELEFANT, E; COURNOT, M.-P; VAUZELLE, C et al.La Lettre du gynécologue. 2007, Num 323, issn 0759-1594, 14Article

Leukoencephalopathy around a tumor cyst following intracystic methotrexate injectionYANO, Tamami; SAWAISHI, Yukio; HIRAYAMA, Aya et al.Pediatric neurology. 2005, Vol 32, Num 1, pp 68-71, issn 0887-8994, 4 p.Article

  • Page / 109